Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayers
JH Rand, XX Wu, AS Quinn, PP Chen… - Blood, The Journal …, 2008 - ashpublications.org
Abstract Treatment with the antimalarial drug hydroxychloroquine (HCQ) has been
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …
[HTML][HTML] Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayers
JH Rand, XX Wu, AS Quinn, PP Chen, JJ Hathcock… - Blood, 2008 - Elsevier
Abstract Treatment with the antimalarial drug hydroxychloroquine (HCQ) has been
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …
[HTML][HTML] Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayers
JH Rand, XX Wu, AS Quinn, PP Chen, JJ Hathcock… - Blood, 2008 - ncbi.nlm.nih.gov
Abstract Treatment with the antimalarial drug hydroxychloroquine (HCQ) has been
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers
JH Rand, XX Wu, AS Quinn, PP Chen… - …, 2008 - pubmed.ncbi.nlm.nih.gov
Treatment with the antimalarial drug hydroxychloroquine (HCQ) has been associated with
reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) and, in an animal …
reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) and, in an animal …
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayers
JH Rand, XX Wu, AS Quinn, PP Chen, JJ Hathcock… - Blood, 2008 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Treatment with the antimalarial drug
hydroxychloroquine (HCQ) has been associated with reduced risk of thrombosis in the …
hydroxychloroquine (HCQ) has been associated with reduced risk of thrombosis in the …
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.
JH Rand, XX Wu, AS Quinn, PP Chen, JJ Hathcock… - Blood, 2008 - europepmc.org
Abstract Treatment with the antimalarial drug hydroxychloroquine (HCQ) has been
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …
[引用][C] Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-β2-glycoprotein I complexes to phospholipid bilayers
JH RAND, XX WU, AS QUINN, PP CHEN… - Blood, 2008 - pascal-francis.inist.fr
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-β2-glycoprotein
I complexes to phospholipid bilayers CNRS Inist Pascal-Francis CNRS Pascal and Francis …
I complexes to phospholipid bilayers CNRS Inist Pascal-Francis CNRS Pascal and Francis …
[PDF][PDF] Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–2-glycoprotein I complexes to phospholipid bilayers
JH Rand, XX Wu, AS Quinn, PP Chen, JJ Hathcock… - BLOOD, 2008 - Citeseer
2GPI complexes on phospholipid bilayers. HCQ, at concentrations of 1 g/mL and greater,
significantly reduced the binding of aPL-2GPI complexes to phospholipid surfaces and THP …
significantly reduced the binding of aPL-2GPI complexes to phospholipid surfaces and THP …
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-β2-glycoprotein I complexes to phospholipid bilayers.
JH Rand, XX Wu, AS Quinn, PP Chen, JJ Hathcock… - 2008 - cabidigitallibrary.org
Abstract Treatment with the antimalarial drug hydroxychloroquine (HCQ) has been
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …
Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.
JH Rand, XX Wu, AS Quinn, PP Chen, JJ Hathcock… - Blood, 2008 - europepmc.org
Abstract Treatment with the antimalarial drug hydroxychloroquine (HCQ) has been
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …
associated with reduced risk of thrombosis in the antiphospholipid (aPL) syndrome (APS) …